Pet Veterinary Drug refers to a drug used in the diagnosis, cure, mitigation, treatment or prevention of diseases in pets.
The global Pet Veterinary Drug market is projected to grow from US$ 9099 million in 2024 to US$ 12120 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.9% during the forecast period.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 鈧�6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 47%.
Report Covers:
This report presents an overview of global market for Pet Veterinary Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pet Veterinary Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pet Veterinary Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pet Veterinary Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pet Veterinary Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pet Veterinary Drug sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Bayer AG
Merck Animal Health
Elanco Animal Health Inc.
Virbac Group
Ceva
Dechra Pharmaceuticals Plc
Vetoquinol
Orion Corporation
Segment by Type
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Drug Stores
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pet Veterinary Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pet Veterinary Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Veterinary Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Pet Veterinary Drug Product Introduction
1.2 Market by Type
1.2.1 Global Pet Veterinary Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Anti-Infectives
1.2.3 Anti-Inflammatory
1.2.4 Parasiticides
1.2.5 Analgesics
1.2.6 Sedatives
1.2.7 Others
1.3 Market by Application
1.3.1 Global Pet Veterinary Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Drug Stores
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pet Veterinary Drug Sales Estimates and Forecasts 2019-2030
2.2 Global Pet Veterinary Drug Revenue by Region
2.2.1 Global Pet Veterinary Drug Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Pet Veterinary Drug Revenue by Region (2019-2024)
2.2.3 Global Pet Veterinary Drug Revenue by Region (2025-2030)
2.2.4 Global Pet Veterinary Drug Revenue Market Share by Region (2019-2030)
2.3 Global Pet Veterinary Drug Sales Estimates and Forecasts 2019-2030
2.4 Global Pet Veterinary Drug Sales by Region
2.4.1 Global Pet Veterinary Drug Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Pet Veterinary Drug Sales by Region (2019-2024)
2.4.3 Global Pet Veterinary Drug Sales by Region (2025-2030)
2.4.4 Global Pet Veterinary Drug Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pet Veterinary Drug Sales by Manufacturers
3.1.1 Global Pet Veterinary Drug Sales by Manufacturers (2019-2024)
3.1.2 Global Pet Veterinary Drug Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pet Veterinary Drug in 2023
3.2 Global Pet Veterinary Drug Revenue by Manufacturers
3.2.1 Global Pet Veterinary Drug Revenue by Manufacturers (2019-2024)
3.2.2 Global Pet Veterinary Drug Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pet Veterinary Drug Revenue in 2023
3.3 Global Key Players of Pet Veterinary Drug, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Pet Veterinary Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pet Veterinary Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pet Veterinary Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pet Veterinary Drug, Product Offered and Application
3.8 Global Key Manufacturers of Pet Veterinary Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pet Veterinary Drug Sales by Type
4.1.1 Global Pet Veterinary Drug Historical Sales by Type (2019-2024)
4.1.2 Global Pet Veterinary Drug Forecasted Sales by Type (2025-2030)
4.1.3 Global Pet Veterinary Drug Sales Market Share by Type (2019-2030)
4.2 Global Pet Veterinary Drug Revenue by Type
4.2.1 Global Pet Veterinary Drug Historical Revenue by Type (2019-2024)
4.2.2 Global Pet Veterinary Drug Forecasted Revenue by Type (2025-2030)
4.2.3 Global Pet Veterinary Drug Revenue Market Share by Type (2019-2030)
4.3 Global Pet Veterinary Drug Price by Type
4.3.1 Global Pet Veterinary Drug Price by Type (2019-2024)
4.3.2 Global Pet Veterinary Drug Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Pet Veterinary Drug Sales by Application
5.1.1 Global Pet Veterinary Drug Historical Sales by Application (2019-2024)
5.1.2 Global Pet Veterinary Drug Forecasted Sales by Application (2025-2030)
5.1.3 Global Pet Veterinary Drug Sales Market Share by Application (2019-2030)
5.2 Global Pet Veterinary Drug Revenue by Application
5.2.1 Global Pet Veterinary Drug Historical Revenue by Application (2019-2024)
5.2.2 Global Pet Veterinary Drug Forecasted Revenue by Application (2025-2030)
5.2.3 Global Pet Veterinary Drug Revenue Market Share by Application (2019-2030)
5.3 Global Pet Veterinary Drug Price by Application
5.3.1 Global Pet Veterinary Drug Price by Application (2019-2024)
5.3.2 Global Pet Veterinary Drug Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Pet Veterinary Drug Market Size by Type
6.1.1 US & Canada Pet Veterinary Drug Sales by Type (2019-2030)
6.1.2 US & Canada Pet Veterinary Drug Revenue by Type (2019-2030)
6.2 US & Canada Pet Veterinary Drug Market Size by Application
6.2.1 US & Canada Pet Veterinary Drug Sales by Application (2019-2030)
6.2.2 US & Canada Pet Veterinary Drug Revenue by Application (2019-2030)
6.3 US & Canada Pet Veterinary Drug Market Size by Country
6.3.1 US & Canada Pet Veterinary Drug Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Pet Veterinary Drug Sales by Country (2019-2030)
6.3.3 US & Canada Pet Veterinary Drug Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pet Veterinary Drug Market Size by Type
7.1.1 Europe Pet Veterinary Drug Sales by Type (2019-2030)
7.1.2 Europe Pet Veterinary Drug Revenue by Type (2019-2030)
7.2 Europe Pet Veterinary Drug Market Size by Application
7.2.1 Europe Pet Veterinary Drug Sales by Application (2019-2030)
7.2.2 Europe Pet Veterinary Drug Revenue by Application (2019-2030)
7.3 Europe Pet Veterinary Drug Market Size by Country
7.3.1 Europe Pet Veterinary Drug Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Pet Veterinary Drug Sales by Country (2019-2030)
7.3.3 Europe Pet Veterinary Drug Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pet Veterinary Drug Market Size
8.1.1 China Pet Veterinary Drug Sales (2019-2030)
8.1.2 China Pet Veterinary Drug Revenue (2019-2030)
8.2 China Pet Veterinary Drug Market Size by Application
8.2.1 China Pet Veterinary Drug Sales by Application (2019-2030)
8.2.2 China Pet Veterinary Drug Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pet Veterinary Drug Market Size by Type
9.1.1 Asia Pet Veterinary Drug Sales by Type (2019-2030)
9.1.2 Asia Pet Veterinary Drug Revenue by Type (2019-2030)
9.2 Asia Pet Veterinary Drug Market Size by Application
9.2.1 Asia Pet Veterinary Drug Sales by Application (2019-2030)
9.2.2 Asia Pet Veterinary Drug Revenue by Application (2019-2030)
9.3 Asia Pet Veterinary Drug Sales by Region
9.3.1 Asia Pet Veterinary Drug Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Pet Veterinary Drug Revenue by Region (2019-2030)
9.3.3 Asia Pet Veterinary Drug Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pet Veterinary Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Pet Veterinary Drug Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Pet Veterinary Drug Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Pet Veterinary Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Pet Veterinary Drug Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Pet Veterinary Drug Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Pet Veterinary Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Pet Veterinary Drug Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Pet Veterinary Drug Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Pet Veterinary Drug Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Boehringer Ingelheim International GmbH
11.1.1 Boehringer Ingelheim International GmbH Company Information
11.1.2 Boehringer Ingelheim International GmbH Overview
11.1.3 Boehringer Ingelheim International GmbH Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Boehringer Ingelheim International GmbH Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boehringer Ingelheim International GmbH Recent Developments
11.2 Zoetis Animal Healthcare
11.2.1 Zoetis Animal Healthcare Company Information
11.2.2 Zoetis Animal Healthcare Overview
11.2.3 Zoetis Animal Healthcare Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Zoetis Animal Healthcare Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Zoetis Animal Healthcare Recent Developments
11.3 Bayer AG
11.3.1 Bayer AG Company Information
11.3.2 Bayer AG Overview
11.3.3 Bayer AG Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Bayer AG Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer AG Recent Developments
11.4 Merck Animal Health
11.4.1 Merck Animal Health Company Information
11.4.2 Merck Animal Health Overview
11.4.3 Merck Animal Health Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Merck Animal Health Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Animal Health Recent Developments
11.5 Elanco Animal Health Inc.
11.5.1 Elanco Animal Health Inc. Company Information
11.5.2 Elanco Animal Health Inc. Overview
11.5.3 Elanco Animal Health Inc. Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Elanco Animal Health Inc. Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Elanco Animal Health Inc. Recent Developments
11.6 Virbac Group
11.6.1 Virbac Group Company Information
11.6.2 Virbac Group Overview
11.6.3 Virbac Group Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Virbac Group Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Virbac Group Recent Developments
11.7 Ceva
11.7.1 Ceva Company Information
11.7.2 Ceva Overview
11.7.3 Ceva Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Ceva Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ceva Recent Developments
11.8 Dechra Pharmaceuticals Plc
11.8.1 Dechra Pharmaceuticals Plc Company Information
11.8.2 Dechra Pharmaceuticals Plc Overview
11.8.3 Dechra Pharmaceuticals Plc Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Dechra Pharmaceuticals Plc Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dechra Pharmaceuticals Plc Recent Developments
11.9 Vetoquinol
11.9.1 Vetoquinol Company Information
11.9.2 Vetoquinol Overview
11.9.3 Vetoquinol Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Vetoquinol Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Vetoquinol Recent Developments
11.10 Orion Corporation
11.10.1 Orion Corporation Company Information
11.10.2 Orion Corporation Overview
11.10.3 Orion Corporation Pet Veterinary Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Orion Corporation Pet Veterinary Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Orion Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pet Veterinary Drug Industry Chain Analysis
12.2 Pet Veterinary Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pet Veterinary Drug Production Mode & Process
12.4 Pet Veterinary Drug Sales and Marketing
12.4.1 Pet Veterinary Drug Sales Channels
12.4.2 Pet Veterinary Drug Distributors
12.5 Pet Veterinary Drug Customers
13 Market Dynamics
13.1 Pet Veterinary Drug Industry Trends
13.2 Pet Veterinary Drug Market Drivers
13.3 Pet Veterinary Drug Market Challenges
13.4 Pet Veterinary Drug Market Restraints
14 Key Findings in The Global Pet Veterinary Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Boehringer Ingelheim International GmbH
Zoetis Animal Healthcare
Bayer AG
Merck Animal Health
Elanco Animal Health Inc.
Virbac Group
Ceva
Dechra Pharmaceuticals Plc
Vetoquinol
Orion Corporation
听
听
*If Applicable.